A pharmaceutical profile of diabetic patients

Marc Rendell, William D. Lassek, David A. Ross, Cynthia Smith, Steven Kernek, Julia Williams, Melva Brown, Laura Willingmyre, Lawrence Yamamoto

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Although there have been innumerable studies documenting various aspects of the morbidity caused by diabetes mellitus in the population, very little attention has been paid to patterns of therapeutic management of diabetic patients. The Unitied States Public Health Service Ambulatory Care Data System (USPHS ACDS), a computerized patient information entry and recording system with a complete pharmaceutical record for each patient, was used to compare patterns of pharmaceutical consumption among diabetic patients as opposed to non-diabetic patients in a population of approximately 90,000 individuals. Drug use by diabetics was significantly higher than by non-diabetics. Cardiovascular drug use, in particular, was considerably higher. Substantially higher consumption of anti-lipemic agents, anti-gout drugs, anti-hypertensives, sedatives and tranquilizers was also found in the diabetic population. The higher use of all drugs by diabetics could be partially explained by a demonstrably higher frequency of out-patient visits by diabetics. However this factor alone could not account for very much higher use of certain selective drug groups by the diabetics. In most cases, these selective increases among the diabetics paralleled expected patterns of disease for which those drug groups are prescribed. The investigation of pharmacotherapeutic profiles of the diabetic population adds a new dimension to the epidemiological study of this disease.

Original languageEnglish
Pages (from-to)193-202
Number of pages10
JournalJournal of Chronic Diseases
Volume36
Issue number2
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Pharmaceutical Preparations
Population
Cardiovascular Agents
United States Public Health Service
Gout
Ambulatory Care
Hypnotics and Sedatives
Information Systems
Antihypertensive Agents
Epidemiologic Studies
Diabetes Mellitus
Outpatients
Morbidity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this

Rendell, M., Lassek, W. D., Ross, D. A., Smith, C., Kernek, S., Williams, J., ... Yamamoto, L. (1983). A pharmaceutical profile of diabetic patients. Journal of Chronic Diseases, 36(2), 193-202. https://doi.org/10.1016/0021-9681(83)90093-0

A pharmaceutical profile of diabetic patients. / Rendell, Marc; Lassek, William D.; Ross, David A.; Smith, Cynthia; Kernek, Steven; Williams, Julia; Brown, Melva; Willingmyre, Laura; Yamamoto, Lawrence.

In: Journal of Chronic Diseases, Vol. 36, No. 2, 1983, p. 193-202.

Research output: Contribution to journalArticle

Rendell, M, Lassek, WD, Ross, DA, Smith, C, Kernek, S, Williams, J, Brown, M, Willingmyre, L & Yamamoto, L 1983, 'A pharmaceutical profile of diabetic patients', Journal of Chronic Diseases, vol. 36, no. 2, pp. 193-202. https://doi.org/10.1016/0021-9681(83)90093-0
Rendell M, Lassek WD, Ross DA, Smith C, Kernek S, Williams J et al. A pharmaceutical profile of diabetic patients. Journal of Chronic Diseases. 1983;36(2):193-202. https://doi.org/10.1016/0021-9681(83)90093-0
Rendell, Marc ; Lassek, William D. ; Ross, David A. ; Smith, Cynthia ; Kernek, Steven ; Williams, Julia ; Brown, Melva ; Willingmyre, Laura ; Yamamoto, Lawrence. / A pharmaceutical profile of diabetic patients. In: Journal of Chronic Diseases. 1983 ; Vol. 36, No. 2. pp. 193-202.
@article{e33827b10a0b49c696b927ff685a60b6,
title = "A pharmaceutical profile of diabetic patients",
abstract = "Although there have been innumerable studies documenting various aspects of the morbidity caused by diabetes mellitus in the population, very little attention has been paid to patterns of therapeutic management of diabetic patients. The Unitied States Public Health Service Ambulatory Care Data System (USPHS ACDS), a computerized patient information entry and recording system with a complete pharmaceutical record for each patient, was used to compare patterns of pharmaceutical consumption among diabetic patients as opposed to non-diabetic patients in a population of approximately 90,000 individuals. Drug use by diabetics was significantly higher than by non-diabetics. Cardiovascular drug use, in particular, was considerably higher. Substantially higher consumption of anti-lipemic agents, anti-gout drugs, anti-hypertensives, sedatives and tranquilizers was also found in the diabetic population. The higher use of all drugs by diabetics could be partially explained by a demonstrably higher frequency of out-patient visits by diabetics. However this factor alone could not account for very much higher use of certain selective drug groups by the diabetics. In most cases, these selective increases among the diabetics paralleled expected patterns of disease for which those drug groups are prescribed. The investigation of pharmacotherapeutic profiles of the diabetic population adds a new dimension to the epidemiological study of this disease.",
author = "Marc Rendell and Lassek, {William D.} and Ross, {David A.} and Cynthia Smith and Steven Kernek and Julia Williams and Melva Brown and Laura Willingmyre and Lawrence Yamamoto",
year = "1983",
doi = "10.1016/0021-9681(83)90093-0",
language = "English",
volume = "36",
pages = "193--202",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - A pharmaceutical profile of diabetic patients

AU - Rendell, Marc

AU - Lassek, William D.

AU - Ross, David A.

AU - Smith, Cynthia

AU - Kernek, Steven

AU - Williams, Julia

AU - Brown, Melva

AU - Willingmyre, Laura

AU - Yamamoto, Lawrence

PY - 1983

Y1 - 1983

N2 - Although there have been innumerable studies documenting various aspects of the morbidity caused by diabetes mellitus in the population, very little attention has been paid to patterns of therapeutic management of diabetic patients. The Unitied States Public Health Service Ambulatory Care Data System (USPHS ACDS), a computerized patient information entry and recording system with a complete pharmaceutical record for each patient, was used to compare patterns of pharmaceutical consumption among diabetic patients as opposed to non-diabetic patients in a population of approximately 90,000 individuals. Drug use by diabetics was significantly higher than by non-diabetics. Cardiovascular drug use, in particular, was considerably higher. Substantially higher consumption of anti-lipemic agents, anti-gout drugs, anti-hypertensives, sedatives and tranquilizers was also found in the diabetic population. The higher use of all drugs by diabetics could be partially explained by a demonstrably higher frequency of out-patient visits by diabetics. However this factor alone could not account for very much higher use of certain selective drug groups by the diabetics. In most cases, these selective increases among the diabetics paralleled expected patterns of disease for which those drug groups are prescribed. The investigation of pharmacotherapeutic profiles of the diabetic population adds a new dimension to the epidemiological study of this disease.

AB - Although there have been innumerable studies documenting various aspects of the morbidity caused by diabetes mellitus in the population, very little attention has been paid to patterns of therapeutic management of diabetic patients. The Unitied States Public Health Service Ambulatory Care Data System (USPHS ACDS), a computerized patient information entry and recording system with a complete pharmaceutical record for each patient, was used to compare patterns of pharmaceutical consumption among diabetic patients as opposed to non-diabetic patients in a population of approximately 90,000 individuals. Drug use by diabetics was significantly higher than by non-diabetics. Cardiovascular drug use, in particular, was considerably higher. Substantially higher consumption of anti-lipemic agents, anti-gout drugs, anti-hypertensives, sedatives and tranquilizers was also found in the diabetic population. The higher use of all drugs by diabetics could be partially explained by a demonstrably higher frequency of out-patient visits by diabetics. However this factor alone could not account for very much higher use of certain selective drug groups by the diabetics. In most cases, these selective increases among the diabetics paralleled expected patterns of disease for which those drug groups are prescribed. The investigation of pharmacotherapeutic profiles of the diabetic population adds a new dimension to the epidemiological study of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0020654223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020654223&partnerID=8YFLogxK

U2 - 10.1016/0021-9681(83)90093-0

DO - 10.1016/0021-9681(83)90093-0

M3 - Article

VL - 36

SP - 193

EP - 202

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

SN - 0895-4356

IS - 2

ER -